Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Green

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Plos One|December 6, 2008
Urinary alpha1-antichymotrypsin: a biomarker of prion infectionGino Miele, Harald Seeger, Denis Marino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2011
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosisGrant A Hill-Cawthorne, Tom Button, Orla Tuohy, et al.
BMC Neurology|September 23, 2006
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?Constanze Boesenberg-Grosse, Walter J Schulz-Schaeffer, Monika Bodemer, et al.
Plos One|September 4, 2010
Prioritizing land and sea conservation investments to protect coral reefsCarissa J Klein, Natalie C Ban, Benjamin S Halpern, et al.
Plants (Basel, Switzerland)|April 30, 2021
The Diversity of Volatile Compounds in Australia's Semi-Desert Genus <i>Eremophila</i> (Scrophulariaceae)Nicholas J Sadgrove, Guillermo F Padilla-González, Alison Green, et al.
Journal of Neurology|May 16, 2009
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathiesAnna Ladogana, Pascual Sanchez-Juan, Eva Mitrová, et al.
Science Translational Medicine|December 23, 2016
Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob diseaseDaisy Bougard, Jean-Philippe Brandel, Maxime Bélondrade, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Journal of Neurology|March 27, 2007
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosisPascual Sanchez-Juan, Raquel Sánchez-Valle, Alison Green, et al.
Molecular Neurobiology|May 8, 2015
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease DiagnosticMatthias Schmitz, Elisabeth Ebert, Katharina Stoeck, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Plos One|December 6, 2008
Urinary alpha1-antichymotrypsin: a biomarker of prion infectionGino Miele, Harald Seeger, Denis Marino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2011
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosisGrant A Hill-Cawthorne, Tom Button, Orla Tuohy, et al.
BMC Neurology|September 23, 2006
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?Constanze Boesenberg-Grosse, Walter J Schulz-Schaeffer, Monika Bodemer, et al.
Plos One|September 4, 2010
Prioritizing land and sea conservation investments to protect coral reefsCarissa J Klein, Natalie C Ban, Benjamin S Halpern, et al.
Plants (Basel, Switzerland)|April 30, 2021
The Diversity of Volatile Compounds in Australia's Semi-Desert Genus <i>Eremophila</i> (Scrophulariaceae)Nicholas J Sadgrove, Guillermo F Padilla-González, Alison Green, et al.
Journal of Neurology|May 16, 2009
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathiesAnna Ladogana, Pascual Sanchez-Juan, Eva Mitrová, et al.
Science Translational Medicine|December 23, 2016
Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob diseaseDaisy Bougard, Jean-Philippe Brandel, Maxime Bélondrade, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Journal of Neurology|March 27, 2007
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosisPascual Sanchez-Juan, Raquel Sánchez-Valle, Alison Green, et al.
Molecular Neurobiology|May 8, 2015
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease DiagnosticMatthias Schmitz, Elisabeth Ebert, Katharina Stoeck, et al.
Pageof 7